Serum HER-2: sensitivity, specificity, and predictive values for detecting metastatic recurrence in breast cancer patients

Sensitivity of CA 15-3, CEA and serum HER2 in the early detection of recurrence of breast cancer

(2013) Ann Christina Pedersen et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Circulating levels of HER-2/neu oncoprotein in breast cancer

(2012) Rafael Molina et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

HER2 shedding and serum HER2 extracellular domain: Biology and clinical utility in breast cancer

(2011) Chantal Tsé et al.   CANCER TREATMENT REVIEWS

Targeted therapy for HER-2: personalized medicine for her, too

(2011) Bohuslav Melichar et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Serum HER2 testing in patients with HER2-positive breast cancer: the death knell tolls

(2011) Brian Leyland-Jones et al.   LANCET ONCOLOGY

Doit-on doser le marqueur circulant ECD/HER-2 chez les patientes atteintes d’un cancer mammaire ?

(2010) Carole Mathelin et al.   PRESSE MEDICALE

Serum HER-2 concentrations for monitoring women with breast cancer in a routine oncology setting

(2009) Patricia Diana Sørensen et al.   CLINICAL CHEMISTRY AND LABORATORY MEDICINE

Serum HER-2/neuand relative resistance to trastuzumab-based therapy in patients with metastatic breast cancer

(2008) Suhail M. Ali et al.   CANCER